Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CENTRAL GARDEN & PET COCENT · Entity 4307 | Director | August 06, 2020 | August 10, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CENTRAL GARDEN & PET CO
Report date August 06, 2020 · Filed August 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,547 |
Ending reported balance
After 2020-08-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-08-06 · Exercise / conversion · Acquired 4,199 · Balance 4,904 Row 2 · 2020-08-06 · Tax withholding · Disposed 3,357 · Balance 1,547 F1: Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.76 · Expires 2020-08-09 | Direct | 0 |
Reported balance
After 2020-08-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-08-06 · Exercise / conversion · Disposed 4,199 · Balance 0 F2: Options were granted on February 14, 2017, and all shares are vested and have been exercised. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Issuer in payment of the aggregate option exercise price incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise.
F2: Options were granted on February 14, 2017, and all shares are vested and have been exercised.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date November 03, 2009 · Filed November 04, 2009
Section 16 reporting ended · disclosed 2009-11-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 1
1 source rowRow 1 · 2009-11-03 · Disposition to issuer · Disposed 19,158 · Balance 0 F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. |
| Stock Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2009-11-03 · Disposition to issuer · Disposed 2,890.44 · Balance 0 F2: Each unit is the economic equivalent of one share of common stock. F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. |
| Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2009-11-03 · Disposition to issuer · Disposed 17,492.74 · Balance 0 F2: Each unit is the economic equivalent of one share of common stock. F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash.
F2: Each unit is the economic equivalent of one share of common stock.
F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2007 Filed Jun 4, 2007 20:43 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Units · Derivative | 1,359.19 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-07-000054 · col620.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,847.26 Underlying: Common Shares · 1,359.19 shares Expires not disclosed F3 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan. F4 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F5 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan. F4 · derivative.expiration_date: Not Applicable. F7 · balance_after: Includes shares acquired through May 29, 2007 pursuant to a dividend reinvestment feature of the Directors Compensation Plan. Read SEC document |
| June 01, 2007 Filed Jun 4, 2007 20:43 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,018 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-07-000054 · col620.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,280 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| February 01, 2007 Filed Feb 1, 2007 22:58 UTC | Merck & Co., Inc. SGP · Entity 2807 | PurchaseCommon Shares | 3,000 | $24.99 | $74,970.00 |
DisclosureSEC source: 0000310158-07-000004 · col597.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,262 Read SEC document |
| December 01, 2006 Filed Dec 4, 2006 20:49 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Units · Derivative | 2,021.81 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000130 · col585.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,443.28 Underlying: Common Shares · 2,021.81 shares Expires not disclosed F3 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan. F4 · derivative.exercise_price: Not Applicable. F7 · price: Not Applicable. F5 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan. F6 · derivative.expiration_date: Not Applicable. F8 · balance_after: Includes shares acquired through November 30, 2006 pursuant to a dividend reinvestment feature of the Issuer's Directors Stock Award Plan. Read SEC document |
| December 01, 2006 Filed Dec 4, 2006 20:49 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000130 · col585.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,262 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| June 01, 2006 Filed Jun 5, 2006 19:45 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Units · Derivative | 2,334.73 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000086 · col553.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,377.23 Underlying: Common Shares · 2,334.73 shares Expires not disclosed F3 · security: The stock units are held pursuant to a deferral feature of the Directors Compensation Plan. F4 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F5 · derivative.exercise_date: The stock units will be paid in shares of stock in accordance with the Reporting Person's election under the Plan. F4 · derivative.expiration_date: Not Applicable. F7 · balance_after: Includes shares acquired through May 31, 2006 pursuant to a dividend reinvestment feature of the Issuer's Directors Stock Award Plan. Read SEC document |
| June 01, 2006 Filed Jun 5, 2006 19:45 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantCommon Shares | 1,748 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000086 · col553.xml · nonDerivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,748 F1 · security: Shares acquired pursuant to the Directors Compensation Plan. F2 · price: Not Applicable. Read SEC document |
| May 20, 2006 Filed May 23, 2006 19:57 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Units · Derivative | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000060 · col541.xml · derivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,025.27 Underlying: Common Shares · 3,000 shares Expires not disclosed F1 · security: The stock units were credited pursuant to a deferral feature of the Directors Stock Award Plan. F2 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F3 · derivative.exercise_date: The stock units will be paid in shares of stock on dates selected in accordance with the Plan. F2 · derivative.expiration_date: Not Applicable. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Issuer's Directors Stock Award Plan, through February 28, 2006. Read SEC document |
| April 01, 2006 Filed Apr 4, 2006 22:40 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 353.03 | $18.99 | $6,704.04 |
DisclosureSEC source: 0000310158-06-000026 · col525.xml · derivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,778.21 Underlying: Common Shares · 353.03 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of February 28, 2006. Read SEC document |
| January 01, 2006 Filed Jan 4, 2006 19:39 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 1,648.68 | $20.85 | $34,374.98 |
DisclosureSEC source: 0000310158-06-000011 · col507.xml · derivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,417.99 Underlying: Common Shares · 1,648.68 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan and the Directors Stock Equivalency Program. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Stock Equivalency Program, as of November 30, 2005. Read SEC document |
| July 01, 2005 Filed Jul 6, 2005 13:39 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Units · Derivative | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-05-000064 · col490.xml · derivative · entry 2 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Shares · 3,000 shares Expires not disclosed F5 · security: The stock units were credited pursuant to a deferral feature of the Directors Stock Award Plan. F6 · derivative.exercise_price: Not Applicable. F8 · price: Not Applicable. F7 · derivative.exercise_date: The stock units will be paid in shares of stock on dates selected in accordance with the Plan. F6 · derivative.expiration_date: Not Applicable. Read SEC document |
| July 01, 2005 Filed Jul 6, 2005 13:39 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 765.13 | $19.06 | $14,583.38 |
DisclosureSEC source: 0000310158-05-000064 · col490.xml · derivative · entry 1 Colligan Thomas J · CIK 0001295758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 765.13 Underlying: Common Shares · 765.13 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Stock Equivalency Program. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.